XML 39 R24.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2020
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
17.  Stock-Based Compensation

Long-term incentive plan
 
During 1995, the Company established the 1995 Long-Term Incentive Stock Option Plan (the Plan), which permits the granting of stock options (including incentive stock options and nonqualified stock options) stock appreciation rights, restricted or unrestricted stock awards, phantom stock, performance awards or any combination of these to employees, directors or consultants. The Plan was amended and restated effective April 22, 2016 and expires on April 21, 2026; the total number of shares that could be issued under the Plan is 7,500,000. As of December 31, 2020, 4,297,900 shares have been issued under the Plan, zero stock options and 1,719,732 restricted stock units (RSUs) were outstanding under the Plan, while 1,482,368 shares remain for future grants under the Plan.

The Company recognizes compensation expense on a pro rata straight-line basis over the requisite service period for stock-based compensation awards with both graded and cliff vesting terms. The Company recognizes the cumulative effect of a change in the number of awards expected to vest in compensation expense in the period of change. The Company has not capitalized any portion of its stock-based compensation. The Company's forfeiture rate is based on actuals.
 
During the years ended December 31, 2020 and 2019, the Company recognized $0.4 million and $1.4 million, respectively, of stock-based compensation expense under the fair value method. Accordingly, the Company recognized associated deferred income tax expense (benefits) of $220 thousand and $86 thousand, respectively, during the years ended December 31, 2020 and 2019. During the years ended December 31, 2020 and 2019, there were approximately zero and $93 thousand of stock-based compensation expense related to the change in fair value of cash-settled RSUs, which the Company accounts for as a liability.

Stock options

Options to purchase shares of the Company’s common stock under the Plan expire in either seven years or ten years from the date of grant and become exercisable in three, five, or seven installments with a certain percentage of options vesting on the first anniversary of the grant date and additional options vesting on each of the subsequent anniversaries of the grant date, subject to acceleration under certain circumstances.

Information with respect to stock option activity as of and for the year ended December 31, 2020 is as follows:

 
Number
of Shares
  
Weighted
Average
Exercise
Price
  
Aggregate
Intrinsic
Value (in thousands)
  
Weighted
Average
Remaining
Contractual Life
(Years)
 
             
Options outstanding at January 1, 2020
  
5,000
  
$
1.65
       
Options expired
  
(5,000
)
  
-
       
Options outstanding at December 31, 2020
  
-
   
-
  
$
-
   
-
 
Options exercisable at December 31, 2020
  
-
  
$
-
  
$
-
   
-
 

Information with respect to stock option activity as of and for the year ended December 31, 2019 is as follows:

 
Number
of Shares
  
Weighted
Average
Exercise
Price
  
Aggregate
Intrinsic
Value (in thousands)
  
Weighted
Average
Remaining
Contractual Life
(Years)
 
             
Options outstanding at January 1, 2019
  
55,000
  
$
1.87
       
Options exercised
  
(50,000
)
  
1.89
       
Options outstanding at December 31, 2019
  
5,000
   
1.65
  
$
-
   
0.87
 
Options exercisable at December 31, 2019
  
5,000
  
$
-
  
$
-
   
-
 

The Company did not grant stock options during the years ended December 31, 2020, and 2019,

The Company received cash for the exercise price associated with stock options exercised of $0 and $127 thousand during the years ended December 31, 2020 and 2019, respectively. The total intrinsic value realized by participants on stock options exercised was zero during the years ended December 31, 2020 and 2019, respectively.

Restricted Stock Units

During the years ended December 31, 2020 and 2019, the Company issued RSUs to employees which vest upon the achievement of specific market-based or time-based measures. The fair value for RSU's is calculated based on the stock price on the grant date and expensed ratably over the requisite service period, which ranges between one year and five years. The following table summarizes the information about vested and unvested restricted stock units for the years ended December 31, 2020 and 2019.

 
Number of Shares
  
Weighted Average
Fair Value
 
       
Nonvested RSUs at January 1, 2019
  
1,571,525
  
$
1.96
 
RSUs granted
  
918,459
   
2.56
 
RSUs forfeited
  
(64,172
)
  
3.12
 
RSUs vested
  
(452,087
)
  
3.30
 
         
Nonvested RSUs at December 31, 2019
  
1,973,725
  
$
1.49
 
         
Nonvested RSUs at January 1, 2020
  
1,973,725
  
$
1.49
 
RSUs granted
  
689,000
   
1.09
 
RSUs forfeited
  
(534,052
)
  
2.49
 
RSUs vested
  
(408,941
)
  
1.67
 
         
Nonvested RSUs at December 31, 2020
  
1,719,732
  
$
1.36
 

As of December 31, 2020, the Company had $0.1 million of unrecognized compensation expense related to the RSUs expected to be recognized on a pro-rata straight line basis over a weighted average remaining service period of approximately 0.63 years.